CATEGORY : Emmes Data Insights

Life Science Market Reports

Our life science market intelligence products have been recognized by market insiders and outsiders alike for their accuracy, in-depth analysis, and unique insights.

Market Reports

Emmes Data Insights: 3 Trends in Hospital COVID Testing Since April

  The DeciBio Emmes SARS-CoV-2 database launched in April, during the first few weeks of widespread lockdowns, and the team has diligently collected data on testing behaviors at hospitals around

View Details

Emmes Data Insights: Why Large-Scale Antibody Testing Remains Out of Reach

  With its ability to quantify past infections and potential to measure population-level immunity, serology testing adds an attractive tool to the COVID-fighting toolkit. While the initial burst of test

View Details

Emmes Data Insights: Supply-Chain Constraints Hinder Diagnostic Testing Capabilities

  Months into the COVID-19 pandemic, U.S. testing capacity continues to lag behind its goals. The Harvard Global Institute estimated that the U.S should have at least 900,000 SARS-CoV-2 tests

View Details

Emmes Data Insights: Hospital Labs’ Readiness for the Coronavirus Testing Onslaught

  SARS-CoV-2 media attention has largely focused on diagnostic reference labs as they have scaled up testing capacity. However, hospital labs, which drive the vast majority of seasonal respiratory virus

View Details

How can we help?

Avoid blind spots in your market. Get the insights you need to accelerate innovation.

Contact Us